Inspiremd Stock In The News

NSPR Stock  USD 2.71  0.06  2.17%   
Our overall analysis of InspireMD's news coverage and content from conventional and social sources shows investors' bearish mood towards InspireMD. The specific impact of InspireMD news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of InspireMD's overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using InspireMD headlines in addition to utilizing other, more conventional financial analysis modules. Check out InspireMD Backtesting and InspireMD Hype Analysis.
To learn how to invest in InspireMD Stock, please use our How to Invest in InspireMD guide.

InspireMD Today Top News and Investor Outlook

Macroaxis News: globenewswire.com
InspireMD Announces Strategic Agreement ...
https://www.globenewswire.com/news-release/2023/11/27/2786025/0/en/InspireMD-Announces-Strategic-Agreement-with-Jacobs-Institute-to-Execute-Early-Feasibility-Study-of-CGuard-EPS-for-the-Treatment-of-Acute-Stroke-Patients-with-Tandem-Lesions.html
 Neutral
Macroaxis News: globenewswire.com
InspireMD Reports Third Quarter 2023 Financial Results and Provides Business Update
https://www.globenewswire.com/news-release/2023/11/06/2773922/0/en/InspireMD-Reports-Third-Quarter-2023-Financial-Results-and-Provides-Business-Update.html
 Bullish
Macroaxis News: globenewswire.com
InspireMD to Participate in Upcoming November Investor Conferences
https://www.globenewswire.com/news-release/2023/11/02/2772201/0/en/InspireMD-to-Participate-in-Upcoming-November-Investor-Conferences.html
 Neutral
Macroaxis News: globenewswire.com
InspireMD Presents Positive 30-Day Follo...
https://www.globenewswire.com/news-release/2023/11/01/2771630/0/en/InspireMD-Presents-Positive-30-Day-Follow-Up-Results-from-the-C-GUARDIANS-U-S-Investigational-Device-Exemption-IDE-Clinical-Trial-at-VIVA23.html
 Neutral
Macroaxis News: globenewswire.com
InspireMD to Report Third Quarter 2023 Financial Results and Provide Corporate Business Update on Monday, November 6th
https://www.globenewswire.com/news-release/2023/10/30/2769338/0/en/InspireMD-to-Report-Third-Quarter-2023-Financial-Results-and-Provide-Corporate-Business-Update-on-Monday-November-6th.html
 Neutral
Macroaxis News: globenewswire.com
InspireMD Supports CMS’ Final National C...
https://www.globenewswire.com/news-release/2023/10/12/2759105/0/en/InspireMD-Supports-CMS-Final-National-Coverage-Determination-NCD-Expanding-Coverage-of-Carotid-Stenting-CAS-to-Include-Both-Asymptomatic-and-Standard-Risk-Patients.html
 Neutral
Macroaxis News: globenewswire.com
InspireMD Announces Senior Leadership Changes to Support Commercial Growth Initiatives
https://www.globenewswire.com/news-release/2023/10/03/2753471/0/en/InspireMD-Announces-Senior-Leadership-Changes-to-Support-Commercial-Growth-Initiatives.html
 Neutral
Macroaxis News: globenewswire.com
InspireMD Announces Abstract of 30-Day R...
https://www.globenewswire.com/news-release/2023/08/31/2735175/0/en/InspireMD-Announces-Abstract-of-30-Day-Results-from-the-C-Guardians-U-S-Investigational-Device-Exemption-IDE-Clinical-Trial-Accepted-for-Presentation-at-VIVA23.html
 Neutral
Macroaxis News: globenewswire.com
InspireMD Reports Second Quarter 2023 Financial Results and Provides Business Update
https://www.globenewswire.com/news-release/2023/08/08/2720437/0/en/InspireMD-Reports-Second-Quarter-2023-Financial-Results-and-Provides-Business-Update.html
 Bullish
Macroaxis News: globenewswire.com
InspireMD to Report Second Quarter 2023 Financial Results and Provide Corporate Business Update on Tuesday, August 8th
https://www.globenewswire.com/news-release/2023/07/25/2710361/0/en/InspireMD-to-Report-Second-Quarter-2023-Financial-Results-and-Provide-Corporate-Business-Update-on-Tuesday-August-8th.html
 Neutral

InspireMD Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide InspireMD and other traded companies coverage with news coverage. We help investors stay connected with InspireMD headlines for the 8th of January to make an informed investment decision based on correlating the impacts of news items on InspireMD Stock performance. Please note that trading solely based on the InspireMD hype is not for everyone as timely availability and quick action are needed to avoid losses.
InspireMD's linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help InspireMD investors visualize upcoming and past events in order to time the market based on InspireMD noise-free hype analysis.
InspireMD stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the InspireMD earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about InspireMD that are available to investors today. That information is available publicly through InspireMD media outlets and privately through word of mouth or via InspireMD internal channels. However, regardless of the origin, that massive amount of InspireMD data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of InspireMD news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of InspireMD relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to InspireMD's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive InspireMD alpha.

InspireMD Largest EPS Surprises

Earnings surprises can significantly impact InspireMD's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2024-08-05
2024-06-30-0.19-0.22-0.0315 
2024-03-05
2023-12-31-0.19-0.160.0315 
2024-11-04
2024-09-30-0.2-0.16310.036918 
2024-05-13
2024-03-31-0.15-0.21-0.0640 
2023-08-07
2023-06-30-0.3-0.240.0620 
2021-05-10
2021-03-31-0.6-0.530.0711 
View All Earnings Estimates

InspireMD Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to InspireMD Stock. Current markets are slightly bullish. About 58% of major world exchanges and indexes are currently up. See today's market update for more information.
news
12th of December 2024
InspireMD, Inc. CFO Craig Shore to Retire, Company Initiates Search for SuccessorDecember ...
at thelincolnianonline.com 
Macroaxis News: globenewswire.com
9th of December 2024
InspireMD Announces First Patient Enrolled in the CGUARDIANS II Pivotal Study of the CGuar...
at globenewswire.com 
Yahoo News
25th of November 2024
Insider Trading
at finance.yahoo.com 
Yahoo News
14th of November 2024
InspireMD Third Quarter 2024 Earnings US0.16 loss per share
at finance.yahoo.com 
insidermonkey News
13th of November 2024
InspireMD, Inc. Q3 2024 Earnings Call Transcript
at insidermonkey.com 
seekingalpha News
12th of November 2024
InspireMD GAAP EPS of -0.16, revenue of 1.81M beats by 0.07M
at seekingalpha.com 
Macroaxis News: globenewswire.com
8th of November 2024
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635
at globenewswire.com 

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards InspireMD in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, InspireMD's short interest history, or implied volatility extrapolated from InspireMD options trading.

Additional Tools for InspireMD Stock Analysis

When running InspireMD's price analysis, check to measure InspireMD's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InspireMD is operating at the current time. Most of InspireMD's value examination focuses on studying past and present price action to predict the probability of InspireMD's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InspireMD's price. Additionally, you may evaluate how the addition of InspireMD to your portfolios can decrease your overall portfolio volatility.